Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host

BACKGROUND: In 2009 the declaration by the World Health Organization of a global pandemic of influenza-H1N1 virus led to a vaccination campaign to ensure protection for immunocompromised patients. The goal of this study was to determine the efficacy of the 2009 H1N1 vaccine in patients with hematolo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: de Lavallade, Hugues, Garland, Paula, Sekine, Takuya, Hoschler, Katja, Marin, David, Stringaris, Kate, Loucaides, Eva, Howe, Katherine, Szydlo, Richard, Kanfer, Ed, Macdonald, Donald, Kelleher, Peter, Cooper, Nichola, Khoder, Ahmad, Gabriel, Ian H., Milojkovic, Dragana, Pavlu, Jiri, Goldman, John M., Apperley, Jane F., Rezvani, Katayoun
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031700/
https://ncbi.nlm.nih.gov/pubmed/20971824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.032664
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars